Xbrane Biopharma Ab
1 products tracked · names used in filings: Xbrane Biopharma Ab
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Tue 27 Oct 2026🇺🇸 FDA approval
FDA approves biosimilar Lucamzi (ranibizumab-blrz)
Xbrane Biopharma Ab; BLA761187; Biosimilar; injection · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Lucamzi ranibizumab-blrz | Approved | 2026-10-27 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.